Stocks and Investing
Stocks and Investing
Tue, February 18, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Steve Scala Maintained (ABBV) at Buy with Increased Target to $105 on, Feb 18th, 2020
Steve Scala of Cowen & Co., Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $98 to $105 on, Feb 18th, 2020.
Steve has made no other calls on ABBV in the last 4 months.
There are 5 other peers that have a rating on ABBV. Out of the 5 peers that are also analyzing ABBV, 1 agrees with Steve's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Randall Stanicky of "RBC Capital" Maintained at Hold with Increased Target to $94 on, Monday, February 10th, 2020
These are the ratings of the 4 analyists that currently disagree with Steve
- Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $105 on, Monday, February 10th, 2020
- Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $104 on, Monday, February 10th, 2020
- Andrew Baum of "Citigroup" Maintained at Strong Buy with Increased Target to $98 on, Wednesday, November 20th, 2019
- Marc Goodman of "UBS" Maintained at Strong Buy with Increased Target to $96 on, Tuesday, November 19th, 2019